Trial Profile
Phase 2 study of lucitanib in patients with advanced breast cancer
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 29 Feb 2016
Price :
$35
*
At a glance
- Drugs Lucitanib (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- Sponsors Servier
- 29 Feb 2016 New trial record